The Platelet Integrin αIIbβ3 Binds to the RGD and AGD Motifs in Fibrinogen

Chemistry and Biology

Volumn 16, Issue 9, 2009, Pages 990-1000

  Sánchez Cortés, Juan ^a   Mrksich, Milan ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

CELLBIO; CHEMBIO

Indexed keywords

ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; FIBRINOGEN; FIBRINOGEN RECEPTOR; FIBRINOLYTIC AGENT; OLIGOPEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING COMPETITION; CELL ADHESION; CHEMISTRY; CHO CELL; CRICETULUS; HAMSTER; HUMAN; METABOLISM; PROTEIN BINDING; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CELL ADHESION; CHO CELLS; CRICETINAE; CRICETULUS; FIBRINOGEN; FIBRINOLYTIC AGENTS; HUMANS; OLIGOPEPTIDES; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS;

EID: 70349182301     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2009.08.012     Document Type: Article

References (35)

1. Bennett J.S., Shattil S., Power J., and Gartner T. Interaction of fibrinogen with its platelet receptor: differential effects of alpha and gamma chain fibrinogen peptides of the glycoprotein IIb-IIIa complex. J. Biol. Chem. 263 (1988) 12948-12953
2. Bini A., Haidaris P., and Kudryk B. Encyclopedic Reference of Vascular Biology and Pathology. In: Bikfalvi A. (Ed) (2000), Springer, Heidelberg, Germany 107-125
3. Curran M.P., and Keating G.M. Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. Drugs 65 (2005) 2009-2035
4. Dennis M.S., Carter P., and Lazarus R.A. Binding interactions of kistrin with platelet glycoprotein IIb-IIIa: analysis by site-directed mutagenesis. Proteins 15 (1993) 312-321
5. Derda R., Li L., Orner B.P., Lewis R.L., Thomson J.A., and Kiessling L.L. Defined substrates for human embryonic stem cell growth identified from surface arrays. ACS Chem. Biol. 2 (2007) 347-355
6. Doolittle R.F., Goldbaum D.M., and Doolittle L.R. Designation of the sequences involved in the "coiled-coil" interdomainal connections in fibrinogen: construction of an atomic scale study. J. Mol. Biol. 120 (1978) 311-325
7. D'Souza S.E., Ginsberg M., Burke T., and Plow E. The ligand binding site of the platelet integrin receptor GPIIb-IIIA is proximal to the second calcium binding domain of its α subunit. J. Biol. Chem. 265 (1990) 3440-3446
8. D'Souza S.E., Ginsberg M., Burke T., Lam S., and Plow E. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science 242 (1988) 91-93
9. Farrell D.H., Thiagarajan P., Chung D.W., and Davie E.W. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc. Natl. Acad. Sci. USA 89 (1992) 10729-10732
10. Feng Y., and Mrksich M. The synergy peptide PHSRN and the adhesion peptide RGD mediate cell adhesion through a common mechanism. Biochemistry 43 (2004) 15811-15821
11. Ginsberg M.H., Loftus J.C., and Plow E.F. Ligand binding to integrins: common and ligand-specific recognition mechanisms. Cell Differ. Dev. 32 (1990) 203-213
12. Hantgan R.R., Stahle M.C., Connor J.H., Horita D.A., Rocco M., McLane M.A., Yakovlev S., and Medved L. Integrin αIIbß3: ligand interactions are linked to binding-site remodeling. Protein Sci. 15 (2006) 1893-1906
13. Haubner R., Gratias R., Diefenbach B., Goodman S., Jonczyk A., and Kessler H. Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin αVβ3 antagonists. J. Am. Chem. Soc. 118 (1996) 7461-7472
14. Hawiger J., Timmons S., Kloczewiak M., Strong D., and Doolittle R. Gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 2068-2071
15. Holmbäck K., Danton M.J.S., Suh T.T., Daugherty C.C., and Degen J.L. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin αIIbß3. EMBO J. 15 (1996) 5760-5771
16. Houseman B.T., Gawalt E.S., and Mrksich M. Maleimide-functionalized self-assembled monolayers for the preparation of peptide and carbohydrate biochips. Langmuir 19 (2003) 1522-1531
17. Hu D.D., White C.A., Panzer-Knodle S., Page J.D., Nicholson N., and Smith J.W. A new model of dual interacting ligand binding sites on integrin αIIbß3. J. Biol. Chem. 274 (1999) 4633-4639
18. Humphries J.D., Byron A., and Humphries M.J. Integrin ligands at a glance. J. Cell Sci. 119 (2006) 3901-3903
19. Kato M., and Mrksich M. Using model substrates to study the dependence of focal adhesion formation on the affinity of integrin-ligand complexes. Biochemistry 43 (2004) 2699-2707
20. Kloczewiak M., Timmons S., Lukas T., and Hawiger J. Platelet receptor recognition site on human fibrinogen: synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain. Biochemistry 23 (1984) 1767-1774
21. Kunicki T.J. Platelet membrane glycoproteins and their function: an overview. Blut 59 (1989) 30-34
22. Lam S.C., Plow E., Smith M., Andriux A., Ryckwaert J., Margerie G., and Ginsberg M. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen γ chain peptides share a common binding site on platelets. J. Biol. Chem. 262 (1987) 947-950
23. Lele M., Sajid M., Wajih N., and Stouffer G.A. Eptifibatide and 7E3, but not triptofiban, inhibit αVβ3 integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin. Circulation 104 (2001) 582-587
24. Li R., Hoess R., Bennett J., and DeGrado W. Use of phage display to probe the evolution of binding specificity and affinity in integrins. Protein Eng. 16 (2003) 65-72
25. Mrksich M. Using self-assembled monolayers to mimic the extracellular matrix. Acta Biomater. 5 (2009) 832-841
26. Murphy W.L., Mercurius K.O., and Mrksich M. Substrates for cell adhesion prepared via active site-directed immobilization of a protein domain. Langmuir 20 (2004) 1026-1030
27. Oshiwaka K., and Terada S. Ussuristatin 2, a novel KGD-bearing disintegrin from Agkistrodon ussuriensis venom. J. Biochem. 125 (1999) 31-35
28. Plow E.F., Pierscbacher M.D., Rouslahti E., Marguerie G.A., and Ginsberg M.H. The effect of Arg-Gly-Asp containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc. Natl. Acad. Sci. USA 82 (1985) 8057-8061
29. Salsmann A., Schaffner-Reckinger E., Kabile F., Plançon S., and Kieffer N. A new functional role of the fibrinogen RGD motif as the molecular switch that selectively triggers integrin αIIbß3-dependent RhoA activation during cell spreading. J. Biol. Chem. 280 (2005) 33610-33619
30. Scarborough R.M. Development of eptifibatide. Am. Heart J. 138 (1999) 1093-1104
31. Scarborough R.M., Rose J.W., Hsu M.A., Phillips D.R., Fried V.A., Campbell A.M., Nannizzi L., and Cahro I.F. Barbourin: A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J. Biol. Chem. 266 (1991) 9359-9362
32. Scarborough R.M., Naughton M.N., Teng W., Rose J.W., Phillips D.R., Nannizzi L., Arfsten A., Campbell A.M., and Cahro I.F. Design of potent and specific integrin antagonists: peptide antagonists with high specificity for glycoprotein IIB-IIIa. J. Biol. Chem. 268 (1993) 1066-1073
33. Springer T.A., Zhu J., and Xiao T. Structural basis for distinctive recognition of fibrinogen γC peptide by the platelet integrin αIIbß3. J. Cell Biol. 182 (2008) 791-800
34. Su J., and Mrksich M. Using mass spectrometry to characterize self-assembled monolayers presenting peptides, proteins and carbohydrates. Angew. Chem. Int. Ed. Engl. 41 (2002) 4715-4718
35. Ugarova T., Budzynski A., Shattil S., Ruggeri Z., Gingsberg M., and Plow E. Conformational changes in fibrinogen elicited by its interaction with platelet membrane glycoprotein GPIIb-IIIA. J. Biol. Chem. 268 (1993) 21080-21087